Transcriptional Fingerprinting meets Drug Discovery


Transcriptional Fingerprinting meets Drug Discovery


Transcriptional Fingerprinting meets Drug Discovery

Mission


 

QUANTRO will combine and exploit innovative technologies in the areas of functional-genetics and transcriptomics to generate an unprecedented cancer drug discovery pipeline transforming the precision and scope of cell-based compound screens.

Read more about the Company & Our Science.

News


 

21.07.2020
QUANTRO Therapeutics Launched with Breakthrough Oncology Drug Discovery Platform 

20.07.2020
QUANTRO joins Vienna Biocenter

20.07.2020
QUANTRO Therapeutics now hiring

Contact

Job Offers

i

Imprint

QUANTRO Therapeutics GmbH
Dr. Bohr-Gasse 7
A-1030 Vienna, Austria

+43 664 9158111

© QUANTRO Therapeutics GmbH